These 2 Nasdaq Biotechs Are Bucking the Market Downtrend

·3 min read
These 2 Nasdaq Biotechs Are Bucking the Market Downtrend

The stock market saw its recent volatility continue on Tuesday morning, as ongoing concerns about longer-term impacts of new COVID-19 variants weighed on market sentiment. As of 11:30 a.m. ET, the Nasdaq Composite (NASDAQINDEX: ^IXIC) had given up early gains and was down 204 points to 15,579. Immunogen (NASDAQ: IMGN) and Molecular Technology (NASDAQ: MOLN) were big gainers on the Nasdaq Tuesday morning, and the news they announced could keep boosting their shares for some time to come.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting